Glycocalyx Impairment in Vascular Disease: Focus on Inflammation
Open Access
- 13 September 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
Abstract
The glycocalyx is a complex polysaccharide-protein layer lining the lumen of vascular endothelial cells. Changes in the structure and function of the glycocalyx promote an inflammatory response in blood vessels and play an important role in the pathogenesis of many vascular diseases (e.g., diabetes, atherosclerosis, and sepsis). Vascular endothelial dysfunction is a hallmark of inflammation-related diseases. Endothelial dysfunction can lead to tissue swelling, chronic inflammation, and thrombosis. Therefore, elimination of endothelial inflammation could be a potential target for the treatment of vascular diseases. This review summarizes the key role of the glycocalyx in the inflammatory process and the possible mechanism by which it alleviates this process by interrupting the cycle of endothelial dysfunction and inflammation. Especially, we highlight the roles of different components of the glycocalyx in modulating the inflammatory process, including components that regulate leukocyte rolling, L-selectin binding, inflammasome activation and the signaling interactions between the glycocalyx components and the vascular cells. We discuss how the glycocalyx interferes with the development of inflammation and the importance of preventing glycocalyx impairment. Finally, drawing on current understanding of the role of the glycocalyx in inflammation, we consider a potential strategy for the treatment of vascular diseases.Keywords
This publication has 76 references indexed in Scilit:
- The Endothelial GlycocalyxAnesthesia & Analgesia, 2013
- Interaction of low molecular weight hyaluronan with CD44 and toll‐like receptors promotes the actin filament‐associated protein 110‐actin binding and MyD88‐NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasionCytoskeleton, 2011
- Hyaluronan reduces inflammation in experimental arthritis by modulating TLR-2 and TLR-4 cartilage expressionBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Activation of the NLRP3 inflammasome by intracellular poly I:CFEBS Letters, 2010
- A chemotactic gradient sequestered on endothelial heparan sulfate induces directional intraluminal crawling of neutrophilsBlood, 2010
- Glycosaminoglycans modulate inflammation and apoptosis in LPS‐treated chondrocytesJournal of Cellular Biochemistry, 2008
- Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injuryAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritisArthritis & Rheumatism, 2005
- Inflammation- and ischemia-induced shedding of venular glycocalyxAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.JCI Insight, 1998